On 15 November, the S|B Health & Life Sciences Day will take as its central theme health innovation and the future of medicines development. It will explore the state of play at the interface between healthcare legislative and regulatory agendas and their R&D equivalents. It will also feature expert roundtables and debates on specific challenges and opportunities that will influence the next era of research-industry collaboration, including issues such as data access and sharing across borders, and the wider implications for health and life sciences in Europe.

Hugues Bultot, Univercells' co-founder & CEO will be one of the guest speakers that day. More information can be found here: https://sciencebusiness.net/events/health-innovation-and-future-medicines-development